Today, Christine Poole commented about whether XYL-N, FTS-T, CNR-T, SHOP-T, ENB-T, BRK.B-N, ATD-T, MFC-T, EMA-T, AMZN-Q, CP-T, SPGI-N, HD-N, BEP.UN-T, WSP-T, ARE-T, L-T, CHP.UN-T, BCE-T, TMO-N, SPOT-N, V-N, T-T, JPM-N are stocks to buy or sell.
Not surprising, given the tariffs. We also saw a lot of pre-buying before tariffs took place. Expectations for May and June are also negative. So we'll probably have negative GDP growth for the quarter as a whole.
A softening, but not necessarily a recession, which is defined as 2 consecutive quarters of negative GDP growth. BOC has been on hold for the last 2 meetings. Arguably, if it were not for the potential impact that tariffs will have on inflation, they may have continued to cut. But they're on hold now so they can see the impact of tariffs.
Despite the negative number, stock markets have actually been quite healthy. TSX at all-time highs, and now US markets are hitting them too. That tells her that expectations are that trade deals will be announced, and they'll be manageable. Corporations will either adjust their supply chains or absorb some of the costs. Potentially not as inflationary as some expected. If so, and especially in Canada with its slowing economic growth and rising unemployment, that gives central banks more leeway to continue cutting interest rates.
Kind of moot. Trump administration has conveyed that if they're talking to the various trading partners, and they can't get a deal signed by that date, there will likely be extensions. Prime Minister Carney announced that Canada hopes to have a trade deal of some kind within 90 days, which would take us beyond July 9. She has the feeling that we'll see extensions.
Right now, she has no exposure to the sector. Very competitive. Decrease in immigration takes away source of potential growth. They all provide a pretty attractive yield. Telus is an income stock, and perhaps they can increase it a bit each year, but the fundamentals of the sector aren't that attractive.
If you hold, sell, and look for a more attractive income stock in a sector with a better outlook.
Challenging year or two. Did well during Covid, then had to normalize. Then rising interest rates impacted spending in biotech. Chinese market's been very soft. Not growing at historical pace, but this should normalize. New US administration's focus on healthcare costs may impact some of TMO's clients.
In the end, one of the leaders in the space. Diverse and extensive international client base. Over the long term, healthcare is a very attractive industry to be in, mainly due to demographics. Attractive multiple.
Real estate arm of WN, which is the parent of Loblaw. Solid, conservative income name; mainly because primary tenant is Loblaw, a very consistent business that isn't going anywhere. Loblaw is actually expanding its discount stores, and CHP.UN would benefit. Pretty safe income stream.
She owns Loblaw for clients.
Likes its positioning in food retail and its pharmaceutical business. Expansion of pharmacists' duties is helping traffic. Discount banners have really been benefiting from softness in the economy, and they have plans to expand the discount footprint. Acquisition of TNT, an Asian chain, is going well.
Total return is positive because of the distribution yield. Rough year for the sector. New US administration doesn't support the sector; removal of tax credits is a headwind. Long-term secular growth theme, with near-term hiccups and volatility. MSFT agreement gives visibility to revenues, other companies want similar agreements.